Last Posted: Aug 16, 2021
- Association of HLA-DRB1 and -DQB1 Alleles with Susceptibility to IgA Nephropathy in Korean Patients.
In Ji Won, et al. Annals of laboratory medicine 2022 1 (1) 54-62
- Association of Immune and Inflammatory Gene Polymorphism With the Risk of IgA Nephropathy: A Systematic Review and Meta-Analysis of 45 Studies.
Ding Xiaonan, et al. Frontiers in immunology 2021 0 683913
- MIR17HG genetic variations affect the susceptibility of IgA nephropathy in Chinese Han people.
Yang Kai, et al. Gene 2021 7 145838
- Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
Sato Yoshinori et al. BMC nephrology 2021 22(1) 230
- RETRACTED: Relationship between the angiotensinogen A1166C gene polymorphism and the risk of diabetes mellitus developing into diabetic nephropathy.
Yang Chun-Hua, et al. Journal of the renin-angiotensin-aldosterone system : JRAAS 2017 1 (4) NP45
- Shared genetic study gives insights into the shared and distinct pathogenic immunity components of IgA nephropathy and SLE.
Zhang Yue-Miao, et al. Molecular genetics and genomics : MGG 2021 6
- Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.
Wang Yan-Na, et al. Journal of the American Society of Nephrology : JASN 2021 2
- Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese.
Zhou Xu-Jie, et al. Clinical journal of the American Society of Nephrology : CJASN 2021 1
- CMIP SNPs and their haplotypes are associated with dyslipidaemia and clinicopathologic features of IgA nephropathy.
Pan Ling, et al. Bioscience reports 2020 0 (10)
- IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank.
Sukcharoen Kittiya, et al. Kidney international reports 2020 10 (10) 1643-1650
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.